Ten‐year observational follow‐up of PROactive: a randomized cardiovascular outcomes trial evaluating pioglitazone in type 2 diabetes
… the 10 years of follow-up (Figure S1). A similar percentage of patients on pioglitazone or placebo groups withdrew consent to follow-up (<1%), were confirmed lost to follow-up (∼9%), …..... Read More